Physician profile
Evan D Muse
NPI 1285883074
$1,941.11
in general payments reported to CMS, 2019-2025
7 companies · $78.26 in 2025
The $78.26 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $852 · 2022: $757 · 2023: $36.04 · 2024: $52.81 · 2025: $78.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,565.65 | 2020-2022 | |
| Medtronic Vascular, INC. | $153.02 | 2019 | |
| Pfizer INC. | $149.21 | 2022-2025 | |
| Cvrx, INC. | $25.49 | 2022 | |
| Merck Sharp & Dohme LLC | $18.45 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $17.59 | 2023 | |
| Janssen Pharmaceuticals, INC | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Muse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.